<DOC>
	<DOC>NCT00440492</DOC>
	<brief_summary>The purpose of this study is to determine if PLA-695 changes the blood concentrations of methotrexate when administered together.</brief_summary>
	<brief_title>Study To Evaluate The Pharmacokinetic Interaction Between PLA-695 And Methotrexate In Adults With Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>Men or women of nonchildbearing potential with rheumatoid arthritis (RA), aged 18 to 75 years RA disease onset after 16 years of age and has had the disease for at least 6 months Must be receiving a stable, welltolerated oral dose of methotrexate (5 to 25 mg) taken once weekly for at least 3 months Evidence of unstable clinically significant disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2007</verification_date>
</DOC>